Neuromedin S: Difference between revisions
CSV import |
No edit summary Tag: Manual revert |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 22: | Line 22: | ||
{{neuropeptide-stub}} | {{neuropeptide-stub}} | ||
{{circadian-rhythm-stub}} | {{circadian-rhythm-stub}} | ||
{{No image}} | |||
Latest revision as of 17:37, 18 March 2025
Neuromedin S is a neuropeptide that is involved in the regulation of circadian rhythms and feeding behavior. It was first identified in 2005 by a team of Japanese researchers who discovered it in the suprachiasmatic nucleus (SCN) of the brain, a region known to control circadian rhythms.
Structure and Function[edit]
Neuromedin S is a 36-amino acid peptide that shares structural similarities with neuromedin U, another neuropeptide. Both peptides belong to the neuromedin family and are characterized by a C-terminal amide group and a six-membered ring structure formed by a disulfide bond.
Neuromedin S binds to the neuromedin U receptor (NMUR), a G protein-coupled receptor, to exert its biological effects. There are two known subtypes of this receptor, NMUR1 and NMUR2, which are expressed in different tissues and have different functions.
In the SCN, neuromedin S is thought to play a crucial role in maintaining circadian rhythms. It does this by synchronizing the activity of SCN neurons, which in turn regulate the timing of various physiological processes, including sleep-wake cycles, hormone secretion, and feeding behavior.
Neuromedin S also influences feeding behavior. Studies in rodents have shown that administration of neuromedin S suppresses food intake, suggesting a role in the regulation of energy balance and body weight.
Clinical Significance[edit]
Given its role in circadian rhythms and feeding behavior, neuromedin S may have implications for a variety of health conditions. For example, disruptions in circadian rhythms have been linked to sleep disorders, mood disorders, and metabolic disorders, among others. Similarly, dysregulation of feeding behavior can contribute to obesity and eating disorders.
Research into neuromedin S is still in its early stages, and much remains to be learned about this neuropeptide. However, it holds promise as a potential target for therapeutic interventions in a range of conditions related to circadian rhythms and energy balance.
This neuropeptide-related article is a stub. You can help WikiMD by expanding it.
This article is a Circadian rhythm-related stub. You can help WikiMD by expanding it!